WILMINGTON, MASSACHUSETTS -- (MARKET WIRE) -- October 17, 2006 -- DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA) today reported that Stiefel Laboratories, Inc., DUSA’s marketing partner for Latin America, has been informed by ANVISA, the Brazilian drug regulatory authorities, that the Levulan® Kerastick® has been approved in Brazil. With DUSA’s support, Stiefel Laboratories completed the regulatory filing with ANVISA during the second quarter of this year.
